Sarah Knaggs

Contact

• workSchool of Veterinary Medicine and Science
  Sutton Bonington Campus
  Sutton Bonington
  Leicestershire
  LE12 5RD
  UK
• work0115 951 6748
• Sarah.Knaggs@nottingham.ac.uk

Biography

Following a PhD in Medicinal Chemistry, I undertook postdoctoral research at the University of Cardiff, University of Reading and Wake-Forest University, USA. I then moved into medical writing, working for a global medical communications agency before moving to the University of Oxford as a Research Facilitator in the Department for Continuing Education (2007-2010). I joined the University of Birmingham College of Medical and Dental Sciences in 2010 as Research Facilitator, before working as a Strategic Projects Manager and, latterly as, Operations Manager (Postgraduate Programmes). I moved to the University of Nottingham School of Veterinary Medicine and Science in December 2015 in the capacity of Research and Business Manager.

Selected Publications

• POOLE LB, KLOMSIRI C, KNAGGS SA, FURDUI CM, NELSON KJ, THOMAS MJ, FETROW JS, DANIEL LW and KING SB, 2007. Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins. Bioconjugate chemistry. 18(6), 2004-17
• POOLE LB, ZENG BB, KNAGGS SA, YAKUBU M and KING SB, 2005. Synthesis of chemical probes to map sulfenic acid modifications on proteins. Bioconjugate chemistry. 16(6), 1624-8
• MCGUIGAN C, HARRIS SA, DALUGE SM, GUDMUNDSSON KS, MCLEAN EW, BURNETTE TC, MARR H, HAZEN R, CONDREAY LD, JOHNSON L, DE CLERCQ E and BALZARINI J, 2005. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency. Journal of medicinal chemistry. 48(10), 3504-15
• KNAGGS S, MALKIN H, OSBORN HM, WILLIAMS NA and YAQOOB P, 2005. New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Organic & biomolecular chemistry. 3(21), 4002-10

• View all publications

• POOLE LB, KLOMSIRI C, KNAGGS SA, FURDUI CM, NELSON KJ, THOMAS MJ, FETROW JS, DANIEL LW and KING SB, 2007. Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins. Bioconjugate chemistry. 18(6), 2004-17
• POOLE LB, ZENG BB, KNAGGS SA, YAKUBU M and KING SB, 2005. Synthesis of chemical probes to map sulfenic acid modifications on proteins. Bioconjugate chemistry. 16(6), 1624-8
• MCGUIGAN C, HARRIS SA, DALUGE SM, GUDMUNDSSON KS, MCLEAN EW, BURNETTE TC, MARR H, HAZEN R, CONDREAY LD, JOHNSON L, DE CLERCQ E and BALZARINI J, 2005. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency. Journal of medicinal chemistry. 48(10), 3504-15
• KNAGGS S, MALKIN H, OSBORN HM, WILLIAMS NA and YAQOOB P, 2005. New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Organic & biomolecular chemistry. 3(21), 4002-10
• HARRIS SA, MCGUIGAN C, ANDREI G, SNOECK R, DE CLERCQ E and BALZARINI J, 2002. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Antiviral chemistry & chemotherapy. 12(5), 293-300
• KNAGGS MH, MCGUIGAN C, HARRIS SA, HESHMATI P, CAHARD D, GILBERT IH and BALZARINI J, 2000. A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T. Bioorganic & medicinal chemistry letters. 10(18), 2075-8
• MCGUIGAN C, SLATER MJ, PARRY NR, PERRY A and HARRIS S, 2000. Synthesis and antiviral activity of acyclovir-5'-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug. Bioorganic & medicinal chemistry letters. 10(7), 645-7